SamaCare
SamaCare operates an AI-native medical benefit prior authorization platform serving U.S. specialty practices and pharmaceutical manufacturers, processing $6.2B+ in specialty drug spend annually across 30,000+ providers. The platform is free to providers; revenue comes from pharma clients paying for market access analytics, intervention services, and industry benchmarks.
- Company typePrivate
- Founded2017
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What SamaCare does
SamaCare operates an AI-native medical benefit prior authorization platform that connects U.S. specialty healthcare providers with pharmaceutical manufacturers through a single unified workflow. Built on a proprietary dataset of over 2 million prior authorizations captured across 30,000+ specialty practices, 97% of U.S. payers, and 8+ years of continuous operation, the platform automates submission, tracking, and denial prevention for high-cost specialty medications administered in retina, oncology, neurology, rheumatology, and infusion settings. Core technology components include a real-time prior authorization data engine, AI-powered point-of-care support, Policy Pre-Check, bulk automated submission, and human-in-the-loop AI processes that learn from frontline specialists. The November 2025 launch of SamaCare Plus extends the platform into touchless, AI-driven prior authorization with provider oversight.
The business model is a two-sided freemium: specialty practices use the core platform free of charge, generating the data asset that underpins SamaCare's value proposition. Revenue is generated on the life sciences side from pharmaceutical manufacturers who subscribe to premium data analytics (SamaCare Insights, Medical Benefit Prior Authorization Benchmarks), intervention services (PA Boost, Auth Inform), and strategic clinical justification support. Distribution combines direct enterprise sales with channel partnerships through Cencora, McKesson, Neuronet GPO, the American Rheumatology Network, NICA, and an EHR integration with NextGen Healthcare. Customers include 40% of leading pharmaceutical companies, with documented outcomes including up to 84% faster time to resolution, 29% higher approval rates, 24% lower patient churn, and up to 42% reduction in avoidable administrative denials. The company is privately held, venture-backed by Questa Capital, Vive Collective, and South Park Commons, and is led by founder and CEO Syam Palakurthy.
SamaCare firmographics
Firmographics- Name
- SamaCare
- Legal name
- SamaCare Inc.
- Website
- https://samacare.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SamaCare operates an AI-native medical benefit prior authorization platform serving U.S. specialty practices and pharmaceutical manufacturers, processing $6.2B+ in specialty drug spend annually across 30,000+ providers. The platform is free to providers; revenue comes from pharma clients paying for market access analytics, intervention services, and industry benchmarks.
- Ownership category
- akta.pro rank
SamaCare industry classification
Industry- Product category
- Medical Benefit Prior Authorization Software
- NAICS
- Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
- akta.pro secondary industry
- DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)
Keywords
Where SamaCare is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SamaCare business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Life Sciences / Pharmaceutical Services: Premium services and data analytics for pharmaceutical brands to improve access to therapy. Revenue generated from pharmaceutical manufacturers who pay for market access insights, intervention support, and data analytics services. Clients include 40% of leading pharmaceutical companies.
- Provider Platform (Free Tier): SamaCare's prior authorization platform is free to clinics, ensuring patients get on the right therapy at the right time. This creates network effects and data advantages that benefit the pharmaceutical side of the business.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free prior authorization platform for providers |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
SamaCare product offering
Product offeringCore offering
SamaCare operates an AI-native medical benefit prior authorization platform, known as the Script-to-Therapy Operating System, that automates submission, tracking, and denial prevention for specialty medications across all major U.S. payers. The platform is offered free to specialty healthcare providers and monetizes via premium data analytics and intervention services sold to pharmaceutical manufacturers, processing over $6.2B in annual specialty drug spend.
Product overview
SamaCare offers a unified Script-to-Therapy Operating System for medical benefit prior authorization, built on a best-in-class AI tech stack and the largest real-world dataset in medical benefit prior authorization. The core platform provides automated, AI-native prior authorization submission and tracking across all major U.S. payers, available free to specialty practices. The product portfolio includes multiple AI-powered modules: SamaCare Plus (touchless prior authorizations), Policy Pre-Check (policy alignment before submission), AI-Powered Point-of-Care Support (real-time denial avoidance guidance), and SamaCare Insights (data analytics for manufacturers). For life sciences clients, SamaCare offers premium services including PA Boost, Auth Inform, and strategic intervention services, along with the Medical Benefit Prior Authorization Benchmarks for industry-wide visibility. The platform processes over $6B+ in medical benefit drug spend annually across more than 15,000 providers and supports 40% of the U.S. ambulatory infusion center market.
Differentiator
Problem solved
Functional benefit
Brands
- SamaCare Insights: AI-powered data analytics and insights platform providing real-time prior authorization performance data and benchmarks.
- AI-Powered Point-of-Care Support
- Policy Pre-Check
- SamaCare Plus
- PA Boost
- Auth Inform
- Script-to-Therapy Operating System
Products and services
- Script-to-Therapy Operating System (Provider Portal)
- SamaCare Plus
- SamaCare Insights
- PA Boost
- Auth Inform
- Medical Benefit Prior Authorization Benchmarks
- Premium Services (Strategic Interventions)
Quantifiable outcome
- Up to 84% faster Time to Resolution
- +6 more outcomes
Companies that use SamaCare
Customer profileNamed customers18 records
Segments3 records
Ideal customer profiles3 records
SamaCare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability5 records
Feature8 records
SamaCare partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- American Rheumatology Network (ARN)coreNational partnership to bring streamlined prior authorization to a network of over 460 community-based rheumatology providers.
- NextGen HealthcarecoreIntegration partnership enabling seamless data transfer between NextGen EHR and SamaCare's prior authorization platform.
- National Infusion Center Association (NICA)coreCo-hosted webinar on unifying prior authorization data for infusion centers; ongoing collaboration on industry standards and education.
- WeInfuseminorCo-presented webinar on infusion operations and workflow automation with leading infusion provider FlexCare.
- Healthcare Business TodayminorContent partnership for article publication on provider-administered drug launches in competitive markets.
- Immunoglobulin National Society (IgNS)minorFeatured partner on Road to Care podcast episode about IG therapy standardization; both organizations focused on improving patient access to specialty therapies.
Scale indicators14 records
Recent moves6 records
Expansion highlights5 records
SamaCare competitors and assessment
Company assessmentDirect peers
- CoverMyMeds: The leading electronic prior authorization (ePA) platform for prescriptions and specialty medications, now part of McKesson's RxTS business. Directly comparable to SamaCare in automating PA workflows between providers, payers, and pharma manufacturers.
- Surescripts: Operates one of the largest ePA networks in the U.S., connecting providers, payers, and pharmacy benefit managers. Comparable to SamaCare as a network-driven prior authorization and medication intelligence infrastructure player.
- Cohere Health: AI-driven prior authorization and utilization management platform focused on specialty care and value-based care arrangements. Direct competitor to SamaCare in automating medical and specialty PA with intelligent clinical decisioning.
Emerging players
- Anterior: AI-native prior authorization company applying large language models to reduce administrative denials. Comparable to SamaCare Plus in targeting touchless PA with deep AI capabilities, though at an earlier stage.
- Notable Health: Intelligent automation platform using AI to streamline administrative workflows for healthcare providers, including prior authorization. Comparable to SamaCare in targeting PA automation and broader workflow reduction with AI.
- Olive AI: Healthcare AI automation company that built workflow automation products including prior authorization. Comparable to SamaCare in deploying AI for repetitive administrative healthcare processes, though with a broader workflow scope.
Broad incumbents
- Waystar: Public healthcare revenue cycle management platform with prior authorization capabilities as part of a broader RCM suite. Overlaps with SamaCare in PA workflows but serves a much wider hospital and ambulatory RCM footprint.
- Optum (UnitedHealth Group): Largest healthcare technology and services platform in the U.S., including Change Healthcare, which provides PA, claims, and clinical connectivity solutions. Competes with SamaCare through vertically integrated payer-provider data and analytics.
- Experian Health: Healthcare data, identity, and automation vendor with prior authorization and eligibility solutions. Comparable to SamaCare in automating medical benefit workflows for providers and payers, but as part of a broader credit and data analytics portfolio.
Others
- Avizia (Amwell): Telehealth platform (acquired by Amwell) that incorporated prior authorization and care navigation into virtual care workflows. Related to SamaCare as an ecosystem participant integrating PA into broader digital care delivery.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
SamaCare social profiles
Digital presenceSamaCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
SamaCare leadership team
Management profileNumber of profiles
Profiles5 records
SamaCare funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SamaCare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SamaCare
What does SamaCare do?
SamaCare operates an AI-native medical benefit prior authorization platform, known as the Script-to-Therapy Operating System, that automates submission, tracking, and denial prevention for specialty medications across all major U.S. payers. The platform is offered free to specialty healthcare providers and monetizes via premium data analytics and intervention services sold to pharmaceutical manufacturers, processing over $6.2B in annual specialty drug spend.
Is SamaCare a public or private company?
SamaCare is a private company. It is classified as venture growth investor backed and is currently operating.
When was SamaCare founded?
SamaCare was founded in 2017. It employs 11 to 50 people.
Where is SamaCare based?
SamaCare is headquartered in San Francisco, United States, in the North America region.
How does SamaCare make money?
Two revenue lines are on record. Life Sciences / Pharmaceutical Services are the primary driver. The others are provider Platform (Free Tier).
Who are SamaCare's main competitors?
Direct peers on record are CoverMyMeds, Surescripts and Cohere Health. Emerging players are Anterior, Notable Health and Olive AI. Broad incumbents are Waystar, Optum (UnitedHealth Group) and Experian Health. Avizia (Amwell) is listed as an others.
Does SamaCare have an API?
No public API is recorded for SamaCare.
What industry is SamaCare in?
SamaCare's product category is Medical Benefit Prior Authorization Software. Its primary akta.pro industry code is HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement, with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 541511 and its SIC code is 7372.